Maravai Lifesciences (MRVI) reported a Q4 adjusted loss of $0.06 per diluted share late Tuesday, swinging from earnings of $0.01 a year earlier.
Analysts polled by FactSet expected an adjusted loss of $0.04.
Revenue for the quarter ended Dec. 31 was $56.6 million, down from $74.1 million a year earlier.
Analysts surveyed by FactSet expected $57.4 million.
Shares of Maravai Lifesciences were down 3.5% in recent after-hours activity.